Obesity is one of the indices of metabolic syndrome and has been implicated in cardiovascular incidents. Atherogenic index of plasma (AIP) has been associated as a biomarker in the predictor of cardiovascular diseases, with remnant cholesterol (RC) suggested as a link to the development of cardiovascular incidents irrespective of body mass index. Objective: The main aim of this current study was to investigate the correlation between AIP and RC among the participants. Materials: A total of 90 participants with average age of 36.05± for normal weight, 36.54±0.7 for overweight and 37.85±2.1 for obese, were enrolled into the study, the participants were categorized based on their BMI. AIP was calculated as Log10 (TG/HDLc), RC was calculated as (TC-HDLc-LDLc), fasting blood was collected for analysis of lipid profile, and fasting blood sugar by standard methods. Data obtained were analyzed using statistical packages for social sciences (SPSS) version 22.0. Results: The values of basic lipid profile and their mathematical derivatives except HDLc were significantly higher in obese and overweight subject when compared to the control (normal weight). In the regression analysis, we found out that subjects with higher AIP shows a tendency of increased risk for the development of obesity and its related complications (OR=2.74, <P 0.001). AIP showed to be a better predictive value for obesity with AUC of 0.8, than other lipid components and derivatives. The Pearson correlation analysis indicates that AIP positively and significantly correlated with RC, BMI, Castelli index I and II, non-HDLc and VLDL and negatively correlated with HDLc across the group. In this study, the analyzed Cardiovascular risk indices were indicative of atherogenicity risk which might help in identifying individuals with abnormal lipid composition at risk of cardiovascular diseases. Our findings suggested that lipid profile derivatives such as Remnant Cholesterol (RC), Atherogenic Index of Plasma (AIP) and Castelli index, could serve as more sensitive cardiovascular risk predictors in the presence of normal value of basic lipid panel test.